VA-2T Pen

Description

Tirzepatide (VA-2T) 30mg: Pre-Formulated Research Pen

VA-2T, Vantage’s catalog name for tirzepatide, supplied as a 30mg pre-formulated solution in a sealed 3 mL research pen for laboratory research. Synthesized in the United States and supplied in solution, with no reconstitution step.

Catalog identity: Previously listed as GLP-2 Tirz Pen, this is Vantage’s VA-2T Pen, SKU VA-GLP2PEN-30MG. VA-2T is Vantage’s catalog name for tirzepatide. This page is the current product listing.

• Strength: 30mg per pen
• Format: Pre-formulated solution, sealed 3 mL pen
• Purity specification: ≥98%
• Origin: U.S. synthesized

Product and Delivery Details

• U.S. synthesized research material, supplied ready to use
• Tracked shipping with delivery confirmation

Documentation

No batch-specific COA is currently published for this pen. The purity specification above is a listed specification, not a published result for this finished pen. Ask about documentation before ordering if your research requires a matching report.

Handling

Store the sealed pen refrigerated at 2 to 8°C, protected from light. Supplied in solution: no reconstitution and no added solvent. Avoid freeze-thaw cycling. Return to refrigeration between uses.

For research use only. Not for human or veterinary use. Not approved by the FDA. 21+

Full reference record, including verified molecular data and the batch COA policy: Tirzepatide.

Ordering for a research organization

For larger research-supply orders, request the Vantage wholesale catalog and private pricing. Wholesale starts at 10 commercial units across available SKUs; mixed products are permitted. Availability, documentation, shipping and payment terms are confirmed in your written quote.